| Pharmaceutical Information |
| Drug Name |
Fotemustine |
| Drug ID |
BADD_D00973 |
| Description |
Not Available |
| Indications and Usage |
|
| Marketing Status |
Not Available |
| ATC Code |
L01AD05 |
| DrugBank ID |
DB04106
|
| KEGG ID |
D07255
|
| MeSH ID |
C054368
|
| PubChem ID |
104799
|
| TTD Drug ID |
D0S1ZB
|
| NDC Product Code |
Not Available |
| Synonyms |
fotemustine | diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate | S 10036 | S-10036 | Muphoran | Mustoforan |
|
| Chemical Information |
| Molecular Formula |
C9H19ClN3O5P |
| CAS Registry Number |
92118-27-9 |
| SMILES |
CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Polyp | 16.02.02.005; 08.01.06.010 | - | - | Not Available | | Hepatobiliary disease | 09.01.08.003 | - | - | Not Available |
|
|
|
